CD33 and Alzheimer disease: The effects of CD33 and its gene polymorphisms on microglia/macrophage-mediated phagocytosis have been most extensively studied in AD, a disease characterized by a failure to clear extracellular amyloid-β (Aβ) peptides from the brain [24].